Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Joint Bone Spine|November 28, 2024
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritisMarion Pons, Stylianos Georgiadis, Mikkel Østergaard, et al.
The Lancet Regional Health. Europe|August 21, 2023
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Health Policy (Amsterdam, Netherlands)|April 17, 2025
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Rheumatology (Oxford, England)|December 23, 2021
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and responseSara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease courseJonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
Nature Immunology|March 6, 2023
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease courseJonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
RMD Open|July 25, 2024
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational studySara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, et al.
Rheumatology (Oxford, England)|July 23, 2024
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitorsPasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, et al.
Annals of the Rheumatic Diseases|September 3, 2020
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countriesRachelle Meisters, Polina Putrik, Sofia Ramiro, et al.
Rheumatology Advances in Practice|November 29, 2024
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a surveyZohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Joint Bone Spine|November 28, 2024
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritisMarion Pons, Stylianos Georgiadis, Mikkel Østergaard, et al.
The Lancet Regional Health. Europe|August 21, 2023
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Health Policy (Amsterdam, Netherlands)|April 17, 2025
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across EuropeBrigitte Michelsen, Mikkel Østergaard, Michael John Nissen, et al.
Rheumatology (Oxford, England)|December 23, 2021
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and responseSara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease courseJonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
Nature Immunology|March 6, 2023
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease courseJonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
RMD Open|July 25, 2024
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational studySara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, et al.
Rheumatology (Oxford, England)|July 23, 2024
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitorsPasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, et al.
Annals of the Rheumatic Diseases|September 3, 2020
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countriesRachelle Meisters, Polina Putrik, Sofia Ramiro, et al.
Rheumatology Advances in Practice|November 29, 2024
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a surveyZohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, et al.
Pageof 13